Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

26 January 2016 : Original article  

The Medically Complex Living Kidney Donor: Glucose Metabolism as Principal Cause of Donor Declination

Martina GuthoffABCDEF, Silvio NadalinADEF, Andreas FritscheADEF, Alfred KönigsrainerDE, Hans-Ulrich HäringDE, Nils HeyneACDEF

DOI: 10.12659/AOT.895729

Ann Transplant 2016; 21:39-45

Abstract

BACKGROUND: Transplant centers are increasingly confronted with medically complex living kidney donor candidates. Considerable differences exist among centers regarding handling of these patients and little data is available on characteristics, evaluation outcome and declination criteria. We now demonstrate impaired glucose metabolism to be the largest single cause of donor declination.

MATERIAL AND METHODS: Follow-up of 133 donor-recipient pairs, presenting to our transplant center between 03/2007 and 06/2012 was included in the analysis. Evaluation outcome of donor-recipient pairs was assessed and declinations stratified into donor or recipient reasons and underlying conditions.

RESULTS: 65 donor-recipient pairs (49%) were accepted for transplantation, 68 (51%) were declined upon first evaluation. 77% of declinations were for donor- and 23% for recipient reasons. Almost half of donor declinations resulted from increased cardiovascular risk with the presence of diabetes mellitus or prediabetes as the largest single cause of declination.

CONCLUSIONS: Glucose metabolism is key in donor risk assessment and precludes kidney donation if abnormal. The high prevalence emphasizes the need for prevention. Prediabetes defines a cohort at risk and response to lifestyle intervention allows for individual risk stratification, thereby potentially increasing the number of persons eligible for kidney donation. Unification of evaluation criteria, as well as prospective long-term follow-up is required to account for increasingly complex living kidney donors.

Keywords: Diabetes Mellitus, Donor Selection, Glucose Metabolism Disorders, Kidney Transplantation, Living Donors, Prediabetic State

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358